Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by SANKAR NAVANEETHAN and MICHAEL HOLLIDAY.
SANKAR NAVANEETHAN
Connection Strength
3.836
MICHAEL HOLLIDAY
  1. Impact of SGLT2 Inhibitors on Glomerular Filtration in Type 1 Diabetes. J Clin Endocrinol Metab. 2026 Jun 17; 111(7):e1912-e1913.
    View in: PubMed
    Score: 0.995
  2. Expanding Evidence for Glucagon-Like Peptide-1 Receptor Agonists in Those with Diabetes and Kidney Disease. Clin J Am Soc Nephrol. 2026 Apr 09.
    View in: PubMed
    Score: 0.983
  3. Emerging evidence for glucagon-like peptide-1 agonists in slowing chronic kidney disease progression. Curr Opin Nephrol Hypertens. 2024 05 01; 33(3):331-336.
    View in: PubMed
    Score: 0.848
  4. Editorial: Advancements in the management of kidney disease and electrolyte derangements. Curr Opin Nephrol Hypertens. 2022 09 01; 31(5):395-398.
    View in: PubMed
    Score: 0.765
  5. Current Insights and Future Directions on the Role of GLP-1 Receptor Agonists in Chronic Kidney Disease. Int J Nephrol Renovasc Dis. 2026; 19:522424.
    View in: PubMed
    Score: 0.245
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.